| [1] |
“Chikungunya epidemiology replace – June 2025,” Who.int. [Online]. Obtainable: https://www.who.int/publications/m/merchandise/chikungunya-epidemiology-update-june-2025. [Accessed: 31-Jul-2025]. |
| [2] |
T. Y. V. de Lima Cavalcanti, M. R. Pereira, S. O. de Paula, and R. F. de O. Franca, “A evaluation on Chikungunya virus epidemiology, pathogenesis and present vaccine improvement,” Viruses, vol. 14, no. 5, p. 969, 2022. |
| [3] |
H. Z. W. Van Bortel Bertrand Sudre, “Chikungunya: Its Historical past in Africa and Asia and Its Unfold to New Areas in 2013–2014,” https://educational.oup.com/, 15-Dec-2016. [Online]. Obtainable: https://educational.oup.com/jid/article/214/suppl_5/S436/2632642. [Accessed: 31-Jul-2025]. |
| [4] |
M. Delrieu et al., “Temperature and transmission of chikungunya, dengue, and Zika viruses: A scientific evaluation of experimental research on Aedes aegypti and Aedes albopictus,” Curr. Res. Parasitol. Vector Borne Dis., vol. 4, p. 100139, 2023. |
| [5] |
“Chikungunya,” Who.int. [Online]. Obtainable: https://www.who.int/news-room/fact-sheets/element/chikungunya. [Accessed: 31-Jul-2025]. |
| [6] |
D. Mavalankar, P. Shastri, T. Bandyopadhyay, J. Parmar, and Ok. V. Ramani, “Elevated mortality fee related to chikungunya epidemic, Ahmedabad, India,” Emerg. Infect. Dis., vol. 14, no. 3, pp. 412–415, 2008. |
| [7] |
Europa.eu. [Online]. Obtainable: https://www.ecdc.europa.eu/en/chikungunya-monthly. [Accessed: 31-Jul-2025]. |
| [8] |
CDC, “About Chikungunya,” Chikungunya Virus, 17-Could-2024. [Online]. Obtainable: https://www.cdc.gov/chikungunya/about/index.html. [Accessed: 31-Jul-2025]. |
| [9] |
L. A. Silva and T. S. Dermody, “Chikungunya virus: epidemiology, replication, illness mechanisms, and potential intervention methods,” J. Clin. Make investments., vol. 127, no. 3, pp. 737–749, 2017. |
| [10] |
W H Ng , Ok Amaral , E Javelle , S Mahalingam, “Continual chikungunya illness (CCD): medical insights, immunopathogenesis and therapeutic views,” https://educational.oup.com/, 20-Feb-2024. [Online]. Obtainable: https://educational.oup.com/qjmed/article/117/7/489/7611656. [Accessed: 31-Jul-2025]. |
| [11] |
J. Ok. Amaral, C. O. Bingham third, P. C. Taylor, L. M. Vilá, M. E. Weinblatt, and R. T. Schoen, “Pathogenesis of persistent chikungunya arthritis: Resemblances and hyperlinks with rheumatoid arthritis,” Journey Med. Infect. Dis., vol. 52, no. 102534, p. 102534, 2023. |
| [12] |
M. van Aalst Charlotte Marieke Nelen Abraham Goorhuis Cornelis Stijnis Martin Peter Grobusch, “Lengthy-term sequelae of chikungunya virus illness: A scientific evaluation,” Sciencedirect.com, 20-Feb-2017. [Online]. Obtainable: https://www.sciencedirect.com/science/article/abs/pii/S1477893917300042. [Accessed: 31-Jul-2025]. |
| [13] |
CDC, “Therapy and prevention of Chikungunya virus illness,” Chikungunya Virus, 16-Could-2025. [Online]. Obtainable: https://www.cdc.gov/chikungunya/hcp/treatment-prevention/index.html. [Accessed: 31-Jul-2025]. |
| [14] |
“FDA Approves First Vaccine to Forestall Illness Brought on by Chikungunya Virus,” Fda.gov, 09-Nov-2023. [Online]. Obtainable: https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-prevent-disease-caused-chikungunya-virus. [Accessed: 31-Jul-2025]. |
| [15] |
“VIMKUNYA,” Fda.gov, 13-Mar-2025. [Online]. Obtainable: https://www.fda.gov/vaccines-blood-biologics/vimkunya. [Accessed: 31-Jul-2025]. |
| [16] |
J. McHugh, “Acute inflammatory arthritis: Lengthy-term results of chikungunya,” Nat. Rev. Rheumatol., vol. 14, no. 2, p. 62, 2018. |
